Hoarding Covid vaccines ‘could cost wealthy countries $4.5tn’
Study suggests vaccinating poorer countries an economic as well as moral imperative
Hoarding Covid-19 vaccines could cost wealthy countries at least $4.5tn (£3.29tn) in lost income this year, according to a new study that argues vaccinating poorer countries against Covid-19 is not just a moral imperative but an economic one.
The cost of fully funding the World Health Organization’s programmes to deliver Covid-19 vaccines and treatments to developing countries – currently $27bn away from their 2021 funding targets – would be dwarfed by the cost of not doing so, according to research commissioned by the International Chamber of Commerce, an international business lobby group, released on Monday.



